Integrating Insulin Delivery and Glucose Sensing in Subcutaneous Tissue for the Treatment of Type-1 Diabetic Patients

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Type 1 Diabetes
Interventions
PROCEDURE

OGTT and CLAMP

"Oral Glucose Tolerance Test (OGTT):~Oral glucose tolerance test combined with subcutaneous insulin delivery and glucose sampling using a single microdialysis or microperfusion probe.~Hyperinsulinemic euglycemic clamp (CLAMP):~Hyperinsulinemic euglycemic clamp with simultaneous subcutaneous insulin delivery and glucose sampling using microdialysis and microperfusion probe."

Trial Locations (1)

A-8036

Medical University of Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT00812591 - Integrating Insulin Delivery and Glucose Sensing in Subcutaneous Tissue for the Treatment of Type-1 Diabetic Patients | Biotech Hunter | Biotech Hunter